151 related articles for article (PubMed ID: 32814633)
21. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of Macrophage Density in the Absence of Neutrophils in Differentiated Thyroid Cancer.
Onuma AE; Schoenfield L; Shen C; Edwards C; Phay JE; Shirley LA; Tsung A
J Surg Res; 2020 Dec; 256():458-467. PubMed ID: 32798993
[TBL] [Abstract][Full Text] [Related]
23. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
24. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
25. Solid Organ Transplantation and Survival among Individuals with a History of Cancer.
Engels EA; Haber G; Hart A; Lynch CF; Li J; Pawlish KS; Qiao B; Yu KJ; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1312-1319. PubMed ID: 33926864
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer.
Waseem Z; Palme CE; Walfish P; Freeman JL
J Otolaryngol; 2004 Dec; 33(6):339-44. PubMed ID: 15971647
[TBL] [Abstract][Full Text] [Related]
27. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
28. [The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)].
Czarniecka A; Jarzab M; Krajewska J; Sacher A; Półtorak S; Włoch J
Endokrynol Pol; 2006; 57(4):347-55. PubMed ID: 17006835
[TBL] [Abstract][Full Text] [Related]
29. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
30. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
[TBL] [Abstract][Full Text] [Related]
31. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
32. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis.
Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C
World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of follicular thyroid carcinoma.
Ríos A; Rodríguez JM; Ferri B; Martínez-Barba E; Torregrosa NM; Parrilla P
Endocrinol Nutr; 2015 Jan; 62(1):11-8. PubMed ID: 25156926
[TBL] [Abstract][Full Text] [Related]
34. Solid organ transplant and thyroid cancer.
Shaha AR
J Surg Oncol; 2017 Feb; 115(2):103-104. PubMed ID: 28054336
[No Abstract] [Full Text] [Related]
35. Partial Thyroidectomy for Papillary Thyroid Microcarcinoma: Is Completion Total Thyroidectomy Indicated?
Donatini G; Castagnet M; Desurmont T; Rudolph N; Othman D; Kraimps JL
World J Surg; 2016 Mar; 40(3):510-5. PubMed ID: 26546190
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
37. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
38. [The results after an organ-preserving operation and total thyroidectomy in differentiated thyroid carcinoma].
Mziuad A; Gavrilov M
Khirurgiia (Sofiia); 1996; 49(6):33-7. PubMed ID: 9173172
[TBL] [Abstract][Full Text] [Related]
39. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
40. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]